Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the combination of MGC018 and MGD019 in participants with advanced solid tumors, including castration-resistant prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Epithelial Ovarian Cancer
• Hepatocellular Carcinoma
• Melanoma
• Pancreatic Ductal Adenocarcinoma
• Renal Cell Carcinoma

Drugs mentioned

• MGC018
• MGD019

Snippet

Sponsor: MacroGenics | Conditions: Advanced Solid Tumor, Castration-Resistant Prostatic Cancer | Phase 1 | Status: COMPLETED